Delivery Order SPE2DB20D3101-SPE2DB23FQUH9
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FF6R5) valued at $1,618.14 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract was awarded on May 18, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a completion date of May 19, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus SoloStar 100 units/mL 3mL insulin pens. The award, valued at $1,424.64, was made by the Defense Logistics Agency (DLA) under a delivery order and has a firm fixed price. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,956.18 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Lantus Solostar 100 Unit/ML 3ML insulin pens to the Defense Logistics Agency (DLA). The $1,980.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024. The contract has an ultimate completion date of December 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,737.90 by the Defense Logistics Agency (DLA) on February 3, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This firm fixed-price, non-set-aside contract is scheduled for completion by February 4, 2026, with performance to be fulfilled at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's broader...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens to the Defense Logistics Agency (DLA). The contract, valued at $1,187.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 1, 2023, with a completion date of June 2, 2023. The contract is a firm fixed-price delivery order and is not designated as a set-aside award. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LANTUS SOLOSTAR insulin pens. The $20,443.62 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 28, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 23, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This firm fixed-price delivery order, valued at $1,299.72, carries an ultimate completion date of January 26, 2026, and will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis, reflecting the company's...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $4,831.88 Firm Fixed Price Delivery Order for Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of December 2, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,827.38 firm fixed price delivery order is for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract has a completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FQUH9Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,455.03 for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML insulin delivery pens. The award was made by the Defense Logistics Agency (DLA), a major component of the Department of Defense responsible for providing medical products and supplies to military healthcare programs. The contract has a completion date of November 9, 2022 and is a Firm Fixed Price arrangement. No set-aside designation was used, indicating the award was made through full and open competition. Amerisourcebergen, a major pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical and medical products to support military healthcare globally. This specific Delivery Order is likely one of many placed against that IDC to fulfill the DLA's requirements for essential diabetes management supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/8/22 |